Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	single-stranded RNA binding	ILF3 HNRNPF HNRNPU DHX9	2.88e-05	111	32	4	GO:0003727
GeneOntologyMolecularFunction	double-stranded RNA binding	ILF3 HNRNPU DHX9	2.62e-04	78	32	3	GO:0003725
GeneOntologyMolecularFunction	promoter-specific chromatin binding	FOXO1 HNRNPU DHX9	3.15e-04	83	32	3	GO:1990841
GeneOntologyMolecularFunction	plus-end-directed microtubule motor activity	KIF3A KIF11	3.33e-04	17	32	2	GO:0008574
GeneOntologyMolecularFunction	mRNA 3'-UTR AU-rich region binding	HNRNPA0 ILF3	9.83e-04	29	32	2	GO:0035925
GeneOntologyMolecularFunction	RNA polymerase II complex binding	HNRNPU DHX9	1.78e-03	39	32	2	GO:0000993
GeneOntologyMolecularFunction	RNA polymerase core enzyme binding	HNRNPU DHX9	2.36e-03	45	32	2	GO:0043175
GeneOntologyMolecularFunction	chromatin DNA binding	FOXO1 HNRNPU DHX9	2.38e-03	167	32	3	GO:0031490
GeneOntologyMolecularFunction	snRNA binding	RBMXL3 HNRNPU	3.76e-03	57	32	2	GO:0017069
GeneOntologyMolecularFunction	ribonucleoprotein complex binding	RBM3 HNRNPU DHX9	4.31e-03	206	32	3	GO:0043021
GeneOntologyMolecularFunction	protein phosphatase binding	FOXO1 AKAP11 KIF3A	4.54e-03	210	32	3	GO:0019903
GeneOntologyMolecularFunction	mRNA binding	HNRNPA0 ILF3 RBMXL3 HNRNPU DHX9	4.62e-03	694	32	5	GO:0003729
GeneOntologyMolecularFunction	general transcription initiation factor binding	HNRNPF HNRNPU	4.71e-03	64	32	2	GO:0140296
GeneOntologyMolecularFunction	RNA polymerase binding	HNRNPU DHX9	4.86e-03	65	32	2	GO:0070063
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	HNRNPU DHX9	5.01e-03	66	32	2	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	HNRNPU DHX9	5.01e-03	66	32	2	GO:0001098
GeneOntologyMolecularFunction	microtubule motor activity	KIF3A KIF11	5.61e-03	70	32	2	GO:0003777
GeneOntologyMolecularFunction	phosphatase binding	FOXO1 AKAP11 KIF3A	8.54e-03	264	32	3	GO:0019902
GeneOntologyMolecularFunction	mRNA 3'-UTR binding	HNRNPA0 ILF3 HNRNPU	9.64e-03	276	32	3	GO:0003730
GeneOntologyBiologicalProcess	positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity	HNRNPU DHX9	2.33e-05	5	32	2	GO:2000373
GeneOntologyBiologicalProcess	regulation of DNA topoisomerase (ATP-hydrolyzing) activity	HNRNPU DHX9	2.33e-05	5	32	2	GO:2000371
GeneOntologyBiologicalProcess	positive regulation of isomerase activity	HNRNPU DHX9	4.87e-05	7	32	2	GO:0010912
GeneOntologyBiologicalProcess	regulation of isomerase activity	HNRNPU DHX9	4.87e-05	7	32	2	GO:0010911
GeneOntologyBiologicalProcess	regulation of mRNA processing	RBMXL3 RBM3 HNRNPU DHX9	1.01e-04	158	32	4	GO:0050684
GeneOntologyBiologicalProcess	CRD-mediated mRNA stabilization	HNRNPU DHX9	1.27e-04	11	32	2	GO:0070934
GeneOntologyBiologicalProcess	negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	HNRNPU DHX9	1.52e-04	12	32	2	GO:1900152
GeneOntologyBiologicalProcess	mRNA processing	HNRNPA0 RBMXL3 RBM3 HNRNPF HNRNPU DHX9	1.77e-04	551	32	6	GO:0006397
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	RBMXL3 RBM3 HNRNPF HNRNPU DHX9	2.10e-04	358	32	5	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	RBMXL3 RBM3 HNRNPF HNRNPU DHX9	2.10e-04	358	32	5	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	RBMXL3 RBM3 HNRNPF HNRNPU DHX9	2.21e-04	362	32	5	GO:0000375
GeneOntologyBiologicalProcess	mRNA stabilization	HNRNPA0 HNRNPU DHX9	2.30e-04	77	32	3	GO:0048255
GeneOntologyBiologicalProcess	regulation of RNA splicing	RBMXL3 RBM3 HNRNPF HNRNPU	2.84e-04	207	32	4	GO:0043484
GeneOntologyBiologicalProcess	positive regulation of cytoplasmic translation	HNRNPU DHX9	3.13e-04	17	32	2	GO:2000767
GeneOntologyBiologicalProcess	negative regulation of mRNA catabolic process	HNRNPA0 HNRNPU DHX9	3.29e-04	87	32	3	GO:1902373
GeneOntologyBiologicalProcess	RNA stabilization	HNRNPA0 HNRNPU DHX9	3.40e-04	88	32	3	GO:0043489
GeneOntologyBiologicalProcess	dendritic transport	KIF3A HNRNPU	3.92e-04	19	32	2	GO:0098935
GeneOntologyBiologicalProcess	negative regulation of RNA catabolic process	HNRNPA0 HNRNPU DHX9	5.10e-04	101	32	3	GO:1902369
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	HNRNPA0 RBMXL3 RBM3 HNRNPU DHX9	5.58e-04	443	32	5	GO:1903311
GeneOntologyBiologicalProcess	positive regulation of mRNA metabolic process	RBMXL3 RBM3 HNRNPU DHX9	6.62e-04	259	32	4	GO:1903313
GeneOntologyBiologicalProcess	negative regulation of mRNA metabolic process	HNRNPA0 HNRNPU DHX9	7.44e-04	115	32	3	GO:1903312
GeneOntologyBiologicalProcess	regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	HNRNPU DHX9	7.99e-04	27	32	2	GO:1900151
GeneOntologyBiologicalProcess	RNA splicing	RBMXL3 RBM3 HNRNPF HNRNPU DHX9	9.79e-04	502	32	5	GO:0008380
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	RBMXL3 RBM3 HNRNPU	1.04e-03	129	32	3	GO:0048024
GeneOntologyCellularComponent	keratohyalin granule	HRNR FLG2	2.26e-05	5	32	2	GO:0036457
GeneOntologyCellularComponent	CRD-mediated mRNA stability complex	HNRNPU DHX9	3.39e-05	6	32	2	GO:0070937
GeneOntologyCellularComponent	spindle microtubule	KIF3A KIF11 HNRNPU	3.06e-04	86	32	3	GO:0005876
GeneOntologyCellularComponent	spliceosomal complex	RBMXL3 RBM3 HNRNPF HNRNPU	3.12e-04	215	32	4	GO:0005681
MousePheno	abnormal germ layer development	CUBN KIF3A HNRNPU DHX9	9.78e-05	144	24	4	MP:0001674
MousePheno	delayed heart looping	FOXO1 KIF3A	1.01e-04	9	24	2	MP:0009328
MousePheno	abnormal motor learning	CNTNAP3 CNTNAP3B PLAT	1.43e-04	60	24	3	MP:0002804
Domain	EGF	CNTNAP3 CNTNAP3B LAMC2 PLAT CUBN PCSK6	2.57e-06	235	32	6	SM00181
Domain	EGF-like_dom	CNTNAP3 CNTNAP3B LAMC2 PLAT CUBN PCSK6	3.58e-06	249	32	6	IPR000742
Domain	Galactose-bd-like	CNTNAP3 CNTNAP3B MYCBP2 PCSK6	1.94e-05	94	32	4	IPR008979
Domain	EGF_1	CNTNAP3 CNTNAP3B LAMC2 PLAT CUBN	6.80e-05	255	32	5	PS00022
Domain	EGF_2	CNTNAP3 CNTNAP3B LAMC2 PLAT CUBN	8.15e-05	265	32	5	PS01186
Domain	-	CNTNAP3 MYCBP2 PCSK6	2.62e-04	73	32	3	2.60.120.260
Domain	RRM_1	HNRNPA0 RBMXL3 RBM3 HNRNPF	4.21e-04	208	32	4	PF00076
Domain	DSRM	ILF3 DHX9	4.78e-04	19	32	2	SM00358
Domain	RRM	HNRNPA0 RBMXL3 RBM3 HNRNPF	4.94e-04	217	32	4	SM00360
Domain	dsrm	ILF3 DHX9	5.30e-04	20	32	2	PF00035
Domain	RRM_dom	HNRNPA0 RBMXL3 RBM3 HNRNPF	5.85e-04	227	32	4	IPR000504
Domain	DS_RBD	ILF3 DHX9	5.85e-04	21	32	2	PS50137
Domain	FA58C	CNTNAP3 CNTNAP3B	5.85e-04	21	32	2	SM00231
Domain	FA58C_3	CNTNAP3 CNTNAP3B	5.85e-04	21	32	2	PS50022
Domain	FA58C_1	CNTNAP3 CNTNAP3B	5.85e-04	21	32	2	PS01285
Domain	FA58C_2	CNTNAP3 CNTNAP3B	5.85e-04	21	32	2	PS01286
Domain	RRM	HNRNPA0 RBMXL3 RBM3 HNRNPF	6.15e-04	230	32	4	PS50102
Domain	EGF_3	CNTNAP3 CNTNAP3B PLAT CUBN	6.66e-04	235	32	4	PS50026
Domain	-	HNRNPA0 RBMXL3 RBM3 HNRNPF	7.67e-04	244	32	4	3.30.70.330
Domain	F5_F8_type_C	CNTNAP3 CNTNAP3B	7.67e-04	24	32	2	PF00754
Domain	FA58C	CNTNAP3 CNTNAP3B	7.67e-04	24	32	2	IPR000421
Domain	Nucleotide-bd_a/b_plait	HNRNPA0 RBMXL3 RBM3 HNRNPF	9.44e-04	258	32	4	IPR012677
Domain	S100_CABP	HRNR FLG2	9.72e-04	27	32	2	PS00303
Domain	S_100	HRNR FLG2	9.72e-04	27	32	2	PF01023
Domain	-	ILF3 DHX9	9.72e-04	27	32	2	3.30.160.20
Domain	EGF-like_CS	CNTNAP3 LAMC2 PLAT CUBN	9.85e-04	261	32	4	IPR013032
Domain	S100_Ca-bd_sub	HRNR FLG2	1.05e-03	28	32	2	IPR013787
Domain	dsRBD_dom	ILF3 DHX9	1.05e-03	28	32	2	IPR014720
Domain	S100/CaBP-9k_CS	HRNR FLG2	1.05e-03	28	32	2	IPR001751
Domain	S_100	HRNR FLG2	1.05e-03	28	32	2	SM01394
Domain	EGF	CNTNAP3 PLAT CUBN	1.29e-03	126	32	3	PF00008
Domain	Fibrinogen_a/b/g_C_dom	CNTNAP3 CNTNAP3B	1.37e-03	32	32	2	IPR002181
Domain	FIBRINOGEN_C_2	CNTNAP3 CNTNAP3B	1.37e-03	32	32	2	PS51406
Domain	FIBRINOGEN_C_1	CNTNAP3 CNTNAP3B	1.37e-03	32	32	2	PS00514
Domain	LAM_G_DOMAIN	CNTNAP3 CNTNAP3B	1.92e-03	38	32	2	PS50025
Domain	Laminin_G_2	CNTNAP3 CNTNAP3B	2.13e-03	40	32	2	PF02210
Domain	Kinesin_motor_CS	KIF3A KIF11	2.24e-03	41	32	2	IPR019821
Domain	Growth_fac_rcpt_	LAMC2 CUBN PCSK6	2.37e-03	156	32	3	IPR009030
Domain	Kinesin-like_fam	KIF3A KIF11	2.46e-03	43	32	2	IPR027640
Domain	KINESIN_MOTOR_1	KIF3A KIF11	2.57e-03	44	32	2	PS00411
Domain	-	KIF3A KIF11	2.57e-03	44	32	2	3.40.850.10
Domain	Kinesin_motor_dom	KIF3A KIF11	2.57e-03	44	32	2	IPR001752
Domain	LamG	CNTNAP3 CNTNAP3B	2.57e-03	44	32	2	SM00282
Domain	Kinesin	KIF3A KIF11	2.57e-03	44	32	2	PF00225
Domain	KISc	KIF3A KIF11	2.57e-03	44	32	2	SM00129
Domain	KINESIN_MOTOR_2	KIF3A KIF11	2.57e-03	44	32	2	PS50067
Domain	zf-RING_2	ZNRF3 MYCBP2	3.57e-03	52	32	2	PF13639
Domain	Laminin_G	CNTNAP3 CNTNAP3B	4.43e-03	58	32	2	IPR001791
Pathway	WP_MRNA_PROCESSING	HNRNPA0 ILF3 RBMXL3 RBM3 HNRNPF HNRNPU DHX9	1.27e-05	451	26	7	MM15946
Pubmed	The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.	HNRNPA0 AKAP11 FASN ILF3 HRNR HNRNPF KIF11 HNRNPU DHX9	1.76e-11	330	33	9	32529326
Pubmed	A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.	HNRNPA0 ILF3 HRNR FLG2 HNRNPF KIF11 HNRNPU DHX9	2.20e-10	286	33	8	32041737
Pubmed	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.	CNTNAP3 FASN ILF3 HRNR FLG2 HNRNPF KIF11 HNRNPU DHX9	1.81e-09	558	33	9	27591049
Pubmed	An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.	FASN ILF3 HRNR FLG2 RBM3 HNRNPF HNRNPU DHX9	2.91e-09	397	33	8	21319273
Pubmed	Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.	HNRNPA0 FASN ILF3 HNRNPF HNRNPU DHX9	3.25e-09	136	33	6	26979993
Pubmed	Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.	HNRNPA0 ILF3 HRNR FLG2 HNRNPF HNRNPU DHX9	4.36e-09	260	33	7	36199071
Pubmed	TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.	HNRNPA0 FASN ILF3 HRNR RBM3 HNRNPF HNRNPU DHX9	5.42e-09	430	33	8	38172120
Pubmed	NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer.	MCCC2 ILF3 FLG2 HNRNPF HNRNPU DHX9	7.13e-09	155	33	6	33838681
Pubmed	Beads-free protein immunoprecipitation for a mass spectrometry-based interactome and posttranslational modifications analysis.	HNRNPA0 ILF3 RBM3 HNRNPF HNRNPU DHX9	1.33e-08	172	33	6	26336360
Pubmed	Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation.	HNRNPA0 FASN HNRNPF KIF11 HNRNPU DHX9	1.33e-08	172	33	6	23184937
Pubmed	Identifying and quantifying in vivo methylation sites by heavy methyl SILAC.	HNRNPA0 ILF3 RBM3 HNRNPU	1.81e-08	30	33	4	15782174
Pubmed	Revealing A-Raf functions through its interactome.	HNRNPA0 ILF3 HRNR HNRNPF HNRNPU DHX9	2.19e-08	187	33	6	29777862
Pubmed	Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.	HNRNPA0 ILF3 RBM3 HNRNPU DHX9	2.32e-08	90	33	5	23151878
Pubmed	Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.	MCCC2 ILF3 HRNR HNRNPU	2.37e-08	32	33	4	36252997
Pubmed	hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.	HNRNPA0 ILF3 HRNR FLG2 HNRNPF HNRNPU DHX9	3.11e-08	346	33	7	25324306
Pubmed	AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis.	HNRNPA0 FASN ILF3 HRNR HNRNPF HNRNPU	3.26e-08	200	33	6	35546148
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	FASN ILF3 ZNRF3 MYCBP2 HNRNPU DHX9	3.46e-08	202	33	6	24639526
Pubmed	Interactomic analysis of REST/NRSF and implications of its functional links with the transcription suppressor TRIM28 during neuronal differentiation.	HNRNPA0 ILF3 RBM3 HNRNPF HNRNPU DHX9	3.78e-08	205	33	6	27976729
Pubmed	Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator.	ILF3 HRNR HNRNPU DHX9	3.87e-08	36	33	4	24147044
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	HNRNPA0 FASN ILF3 MYCBP2 HNRNPF KIF3A KIF11 HNRNPU DHX9	4.46e-08	809	33	9	32129710
Pubmed	Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing.	ILF3 HNRNPF HNRNPU DHX9	5.99e-08	40	33	4	23825951
Pubmed	Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.	HNRNPA0 ILF3 HNRNPF HNRNPU DHX9	6.10e-08	109	33	5	29511296
Pubmed	PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays.	ILF3 HNRNPU DHX9	6.51e-08	9	33	3	11850402
Pubmed	LINC00152 Promotes Tumor Progression and Predicts Poor Prognosis by Stabilizing BCL6 From Degradation in the Epithelial Ovarian Cancer.	FASN HRNR DHX9	9.30e-08	10	33	3	33282727
Pubmed	ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.	HNRNPA0 FASN HRNR FLG2 MYCBP2 HNRNPF HNRNPU DHX9	9.60e-08	624	33	8	33729478
Pubmed	Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1.	HNRNPA0 FASN ILF3 HNRNPF HNRNPU DHX9	9.85e-08	241	33	6	23125841
Pubmed	Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.	HNRNPA0 MCCC2 ILF3 HNRNPF HNRNPU DHX9	1.06e-07	244	33	6	30349055
Pubmed	RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.	HNRNPA0 FASN ILF3 HNRNPF KIF11 HNRNPU DHX9	1.26e-07	425	33	7	21081503
Pubmed	RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.	ILF3 HNRNPU DHX9	1.28e-07	11	33	3	37142680
Pubmed	Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase.	FASN ILF3 HRNR HNRNPF KIF11 HNRNPU	1.41e-07	256	33	6	32698014
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	HNRNPA0 LAMC2 FASN ILF3 HRNR FLG2 HNRNPF KIF11 HNRNPU DHX9	1.59e-07	1257	33	10	36526897
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	HNRNPA0 FASN ILF3 HNRNPF KIF11 HNRNPU DHX9	1.62e-07	441	33	7	31239290
Pubmed	Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells.	HNRNPA0 FASN HNRNPF HNRNPU DHX9	1.91e-07	137	33	5	37039823
Pubmed	Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation.	FASN ILF3 RBM3 HNRNPF HNRNPU DHX9	1.97e-07	271	33	6	26816005
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	HNRNPA0 FASN ILF3 FLG2 RBM3 HNRNPF KIF11 HNRNPU DHX9	2.10e-07	971	33	9	33306668
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	HNRNPA0 FASN ILF3 HNRNPF HNRNPU DHX9	2.10e-07	274	33	6	34244482
Pubmed	Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins.	ILF3 HNRNPU DHX9	2.21e-07	13	33	3	17765891
Pubmed	KAP1 Recruitment of the 7SK snRNP Complex to Promoters Enables Transcription Elongation by RNA Polymerase II.	MCCC2 HRNR FLG2 HNRNPF HNRNPU DHX9	2.43e-07	281	33	6	26725010
Pubmed	High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.	HNRNPA0 LAMC2 FASN ILF3 HNRNPF HNRNPU DHX9	2.45e-07	469	33	7	37314180
Pubmed	Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells.	ILF3 HNRNPF HNRNPU DHX9	2.56e-07	57	33	4	17932509
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	HNRNPA0 FASN ILF3 RBM3 HNRNPF KIF3A HNRNPU DHX9	2.94e-07	723	33	8	34133714
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	HNRNPA0 FASN MCCC2 ILF3 RBM3 HNRNPF HNRNPU DHX9	3.01e-07	725	33	8	27025967
Pubmed	Identification of intracellular proteins associated with the EBV-encoded nuclear antigen 5 using an efficient TAP procedure and FT-ICR mass spectrometry.	HNRNPA0 MCCC2 ILF3 HNRNPU DHX9	3.11e-07	151	33	5	18457437
Pubmed	Proteomic analysis of the cullin 4B interactome using proximity-dependent biotinylation in living cells.	HNRNPA0 ILF3 RBMXL3 RBM3 DHX9	3.32e-07	153	33	5	28225217
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	HNRNPA0 FASN ILF3 HNRNPF KIF11 HNRNPU DHX9	3.47e-07	494	33	7	26831064
Pubmed	Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells.	FASN ILF3 HNRNPF HNRNPU	3.84e-07	63	33	4	17220478
Pubmed	TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.	ILF3 HRNR FLG2	4.32e-07	16	33	3	31823782
Pubmed	Large-scale analysis of the human ubiquitin-related proteome.	HNRNPA0 MYCBP2 RBM3 HNRNPF HNRNPU DHX9	4.57e-07	313	33	6	16196087
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	HNRNPA0 FASN MCCC2 ILF3 FLG2 RBM3 HNRNPF KIF11 HNRNPU DHX9	4.73e-07	1415	33	10	28515276
Pubmed	Functional specialization of beta-arrestin interactions revealed by proteomic analysis.	HNRNPA0 FASN ILF3 HNRNPF KIF3A HNRNPU	4.92e-07	317	33	6	17620599
Pubmed	DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization.	FASN ILF3 MYCBP2 HNRNPF HNRNPU	6.45e-07	175	33	5	25756610
Pubmed	Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.	HNRNPA0 FASN ILF3 RBM3 HNRNPU DHX9	6.68e-07	334	33	6	30425250
Pubmed	BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites.	FASN ILF3 HNRNPU DHX9	6.98e-07	73	33	4	32347575
Pubmed	Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level.	MYCBP2 RBM3 HNRNPF HNRNPU DHX9	7.41e-07	180	33	5	21139048
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	HNRNPA0 ILF3 RBMXL3 RBM3 HNRNPF DHX9	8.34e-07	347	33	6	16033648
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3 CNTNAP3B	8.73e-07	2	33	2	31150793
Pubmed	Selective regulation of gene expression by nuclear factor 110, a member of the NF90 family of double-stranded RNA-binding proteins.	ILF3 DHX9	8.73e-07	2	33	2	12946349
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3 CNTNAP3B	8.73e-07	2	33	2	26807827
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	HNRNPA0 FASN ILF3 HRNR RBMXL3 RBM3 HNRNPF HNRNPU DHX9	8.82e-07	1153	33	9	29845934
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	FASN ILF3 HRNR RBMXL3 RBM3 HNRNPF HNRNPU DHX9	9.44e-07	844	33	8	25963833
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	HNRNPA0 FASN ILF3 HNRNPF KIF11 HNRNPU DHX9	1.04e-06	582	33	7	20467437
Pubmed	Dynamic protein-protein interaction wiring of the human spliceosome.	HNRNPA0 ILF3 HNRNPF HNRNPU DHX9	1.16e-06	197	33	5	22365833
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	HNRNPA0 ILF3 HRNR FLG2 HNRNPF HNRNPU DHX9	1.34e-06	605	33	7	28977666
Pubmed	Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.	FASN MCCC2 ILF3 HNRNPF HNRNPU DHX9	1.35e-06	377	33	6	25147182
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	FASN ILF3 HRNR FLG2 HNRNPF KIF11 DHX9	1.47e-06	613	33	7	22268729
Pubmed	Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.	FASN ILF3 HNRNPF KIF11 HNRNPU DHX9	1.48e-06	383	33	6	29331416
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	HNRNPA0 ILF3 HRNR KIF11 HNRNPU DHX9	1.64e-06	390	33	6	17643375
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	FASN ILF3 HRNR FLG2 HNRNPF HNRNPU DHX9	1.68e-06	626	33	7	33644029
Pubmed	Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.	HNRNPA0 FASN ILF3 FLG2 HNRNPF DHX9	1.93e-06	401	33	6	25852190
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	HNRNPA0 FASN HRNR FLG2 HNRNPF HNRNPU DHX9	1.97e-06	641	33	7	36057605
Pubmed	The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase.	HNRNPA0 ILF3 HNRNPF HNRNPU DHX9	1.99e-06	220	33	5	34091597
Pubmed	A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications.	ILF3 HNRNPF HNRNPU DHX9	2.01e-06	95	33	4	37211047
Pubmed	GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer.	ILF3 HRNR FLG2 KIF11 DHX9	2.12e-06	223	33	5	33731348
Pubmed	Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity.	HNRNPF HNRNPU DHX9	2.51e-06	28	33	3	38492217
Pubmed	CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1.	ILF3 HNRNPF HNRNPU DHX9	2.57e-06	101	33	4	34462429
Pubmed	Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.	HRNR FLG2	2.62e-06	3	33	2	23403047
Pubmed	Human Nup98 regulates the localization and activity of DExH/D-box helicase DHX9.	HNRNPU DHX9	2.62e-06	3	33	2	28221134
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	FASN RBM3 KIF11 HNRNPU DHX9	2.75e-06	235	33	5	30258100
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	HNRNPA0 ILF3 RBM3 HNRNPF KIF11 HNRNPU DHX9	2.85e-06	678	33	7	30209976
Pubmed	The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.	HNRNPA0 ILF3 HNRNPF HNRNPU DHX9	2.98e-06	239	33	5	26641092
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	HNRNPA0 FASN MCCC2 ILF3 RBM3 HNRNPF HNRNPU DHX9	3.07e-06	989	33	8	36424410
Pubmed	Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.	HRNR FLG2 HNRNPU DHX9	3.23e-06	107	33	4	32989256
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HNRNPA0 FASN MCCC2 ILF3 MYCBP2 HNRNPF KIF11 HNRNPU DHX9	3.29e-06	1353	33	9	29467282
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	HNRNPA0 ILF3 HNRNPF HNRNPU DHX9	3.30e-06	244	33	5	29884807
Pubmed	Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.	FASN ILF3 HNRNPF HNRNPU DHX9	3.30e-06	244	33	5	28902428
Pubmed	SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.	ILF3 HRNR FLG2 HNRNPU DHX9	3.36e-06	245	33	5	35652658
Pubmed	Comprehensive proteomic analysis of the human spliceosome.	HNRNPA0 HNRNPF HNRNPU DHX9	3.48e-06	109	33	4	12226669
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	HNRNPA0 FASN ILF3 RBM3 HNRNPF HNRNPU DHX9	3.76e-06	707	33	7	19738201
Pubmed	Shotgun proteomics and network analysis of ubiquitin-related proteins from human breast carcinoma epithelial cells.	HNRNPF HNRNPU DHX9	3.79e-06	32	33	3	21853274
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	HNRNPA0 FASN ILF3 HRNR MYCBP2 HNRNPF HNRNPU DHX9	3.96e-06	1024	33	8	24711643
Pubmed	Mass spectrometry-based proteomics revealed Glypican-1 as a novel ADAM17 substrate.	HNRNPA0 LAMC2 ILF3 HNRNPU	4.46e-06	116	33	4	27576135
Pubmed	A functional interaction between RHA and Ubc9, an E2-like enzyme specific for Sumo-1.	ILF3 DHX9	5.23e-06	4	33	2	15312759
Pubmed	LINKIN, a new transmembrane protein necessary for cell adhesion.	HNRNPA0 FASN ILF3 HNRNPF HNRNPU DHX9	5.41e-06	480	33	6	25437307
Pubmed	Molecular composition of IMP1 ribonucleoprotein granules.	ILF3 HNRNPU DHX9	5.44e-06	36	33	3	17289661
Pubmed	Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass.	MYCBP2 HNRNPF HNRNPU DHX9	5.81e-06	124	33	4	23000965
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	HNRNPA0 ILF3 HRNR FLG2 MYCBP2 HNRNPF HNRNPU DHX9	5.94e-06	1082	33	8	38697112
Pubmed	A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins.	HNRNPF HNRNPU DHX9	6.42e-06	38	33	3	18247557
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	ILF3 KIF11 HNRNPU DHX9	6.59e-06	128	33	4	25332235
Pubmed	Quantitative proteomics reveals that long non-coding RNA MALAT1 interacts with DBC1 to regulate p53 acetylation.	HNRNPA0 ILF3 HNRNPF DHX9	6.80e-06	129	33	4	28973437
Pubmed	Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation.	FASN HNRNPU DHX9	7.51e-06	40	33	3	16210410
Interaction	NDN interactions	FOXO1 HNRNPA0 AKAP11 FASN ILF3 HRNR HNRNPF KIF11 HNRNPU DHX9	1.24e-09	453	32	10	int:NDN
Interaction	RBM45 interactions	HNRNPA0 FASN ILF3 HNRNPF KIF11 HNRNPU DHX9	2.95e-08	207	32	7	int:RBM45
Interaction	FBP1 interactions	HNRNPA0 ILF3 HRNR FLG2 HNRNPF KIF11 HNRNPU DHX9	5.35e-08	348	32	8	int:FBP1
Interaction	NLRP7 interactions	MCCC2 ILF3 FLG2 HNRNPF HNRNPU DHX9	1.81e-07	161	32	6	int:NLRP7
Interaction	CRY1 interactions	FOXO1 FASN ILF3 MYCBP2 HNRNPF HNRNPU	1.87e-07	162	32	6	int:CRY1
Interaction	BTRC interactions	HNRNPA0 MCCC2 ILF3 HRNR FLG2 ZNRF3 MYCBP2 HNRNPF HNRNPU DHX9	2.00e-07	775	32	10	int:BTRC
Interaction	REST interactions	HNRNPA0 FASN ILF3 RBM3 HNRNPF HNRNPU DHX9	2.00e-07	274	32	7	int:REST
Interaction	DCUN1D1 interactions	FASN ILF3 FLG2 RBM3 HNRNPF HNRNPU DHX9	2.05e-07	275	32	7	int:DCUN1D1
Interaction	CUL2 interactions	HNRNPA0 FASN ILF3 HRNR FLG2 RBM3 HNRNPF HNRNPU DHX9	2.32e-07	591	32	9	int:CUL2
Interaction	LINC00624 interactions	MCCC2 ILF3 HRNR HNRNPU	4.14e-07	39	32	4	int:LINC00624
Interaction	DUX4 interactions	FASN ILF3 RBM3 HNRNPF HNRNPU DHX9	9.62e-07	214	32	6	int:DUX4
Interaction	HNRNPA3 interactions	FOXO1 HNRNPA0 FASN MCCC2 ILF3 HNRNPF HNRNPU DHX9	9.95e-07	511	32	8	int:HNRNPA3
Interaction	FBXO6 interactions	CNTNAP3B PLAT FASN ILF3 HRNR FLG2 HNRNPF KIF11 DHX9	1.17e-06	717	32	9	int:FBXO6
Interaction	HNRNPA1 interactions	FOXO1 HNRNPA0 FASN ILF3 HRNR FLG2 RBM3 HNRNPF HNRNPU DHX9	1.23e-06	945	32	10	int:HNRNPA1
Interaction	CYTOR interactions	FASN HRNR DHX9	1.31e-06	14	32	3	int:CYTOR
Interaction	CHMP4B interactions	HNRNPA0 AKAP11 FASN ILF3 HRNR MYCBP2 HNRNPF HNRNPU DHX9	1.31e-06	727	32	9	int:CHMP4B
Interaction	PAGE4 interactions	FASN ILF3 HRNR HNRNPF KIF11 HNRNPU	2.54e-06	253	32	6	int:PAGE4
Interaction	IL7R interactions	HNRNPA0 ILF3 RBM3 HNRNPU DHX9	2.70e-06	141	32	5	int:IL7R
Interaction	LGR4 interactions	FASN ILF3 ZNRF3 MYCBP2 HNRNPU DHX9	3.11e-06	262	32	6	int:LGR4
Interaction	SF3A2 interactions	HNRNPA0 FASN ILF3 RBM3 HNRNPU DHX9	3.94e-06	273	32	6	int:SF3A2
Interaction	LARP7 interactions	HNRNPA0 MCCC2 ILF3 HRNR RBMXL3 FLG2 RBM3 HNRNPF HNRNPU DHX9	5.36e-06	1113	32	10	int:LARP7
Interaction	CYLD interactions	CNTNAP3 FASN ILF3 HRNR FLG2 HNRNPF KIF11 HNRNPU DHX9	5.61e-06	868	32	9	int:CYLD
Interaction	BGLT3 interactions	FASN ILF3 HNRNPU DHX9	5.88e-06	75	32	4	int:BGLT3
Interaction	MATR3 interactions	HNRNPA0 FASN ILF3 MYCBP2 RBM3 HNRNPF HNRNPU DHX9	6.29e-06	655	32	8	int:MATR3
Interaction	CCDC8 interactions	HNRNPA0 FASN ILF3 HRNR MYCBP2 HNRNPF HNRNPU DHX9	6.36e-06	656	32	8	int:CCDC8
Interaction	USP14 interactions	HNRNPA0 FASN ILF3 HRNR RBM3 HNRNPU DHX9	9.43e-06	489	32	7	int:USP14
Interaction	GLDC interactions	HNRNPA0 FASN ILF3 HNRNPF HNRNPU DHX9	9.96e-06	321	32	6	int:GLDC
Interaction	CUL4B interactions	HNRNPA0 ILF3 RBMXL3 MYCBP2 RBM3 HNRNPF KIF11 DHX9	1.36e-05	728	32	8	int:CUL4B
Interaction	PRC1 interactions	HNRNPA0 LAMC2 FASN ILF3 HRNR RBMXL3 HNRNPF HNRNPU DHX9	1.41e-05	973	32	9	int:PRC1
Interaction	RO60 interactions	ILF3 RBM3 HNRNPF HNRNPU DHX9	1.48e-05	200	32	5	int:RO60
Interaction	HNRNPA0 interactions	HNRNPA0 ILF3 RBM3 HNRNPF HNRNPU DHX9	1.60e-05	349	32	6	int:HNRNPA0
Interaction	HNRNPR interactions	HNRNPA0 FASN ILF3 RBM3 HNRNPF HNRNPU DHX9	1.71e-05	536	32	7	int:HNRNPR
Interaction	HNRNPA2B1 interactions	FOXO1 HNRNPA0 ILF3 MYCBP2 RBM3 HNRNPF HNRNPU DHX9	1.75e-05	754	32	8	int:HNRNPA2B1
Interaction	USP11 interactions	HNRNPA0 FASN ILF3 MYCBP2 HNRNPF HNRNPU DHX9	1.77e-05	539	32	7	int:USP11
Interaction	FUS interactions	FOXO1 HNRNPA0 FASN ILF3 MYCBP2 HNRNPF HNRNPU DHX9	1.80e-05	757	32	8	int:FUS
Interaction	HNRNPDL interactions	HNRNPA0 FASN ILF3 HNRNPF HNRNPU DHX9	2.03e-05	364	32	6	int:HNRNPDL
Interaction	KIF23 interactions	FASN ILF3 HRNR RBMXL3 FLG2 HNRNPF KIF11 HNRNPU DHX9	2.24e-05	1031	32	9	int:KIF23
Interaction	CDK2 interactions	FASN ILF3 HRNR FLG2 RBM3 HNRNPF HNRNPU DHX9	2.30e-05	783	32	8	int:CDK2
Interaction	RIOK1 interactions	HNRNPA0 FASN ILF3 HNRNPF KIF11 HNRNPU DHX9	2.32e-05	562	32	7	int:RIOK1
Interaction	ARAF interactions	HNRNPA0 ILF3 HRNR HNRNPF HNRNPU DHX9	2.44e-05	376	32	6	int:ARAF
Interaction	CUL5 interactions	HNRNPA0 FASN ILF3 RBM3 HNRNPF HNRNPU DHX9	2.45e-05	567	32	7	int:CUL5
Interaction	BTF3 interactions	FASN ILF3 HRNR FLG2 HNRNPF KIF11 HNRNPU DHX9	2.66e-05	799	32	8	int:BTF3
Interaction	HNRNPF interactions	FOXO1 HNRNPA0 FASN KRTAP7-1 HNRNPF HNRNPU DHX9	3.79e-05	607	32	7	int:HNRNPF
Interaction	PRR3 interactions	HNRNPA0 ILF3 RBM3 KIF11 HNRNPU	4.00e-05	246	32	5	int:PRR3
Interaction	FN1 interactions	HNRNPA0 PLAT FASN ILF3 RBM3 HNRNPF HNRNPU DHX9	4.07e-05	848	32	8	int:FN1
Interaction	MTF1 interactions	FASN ILF3 HNRNPU DHX9	4.16e-05	123	32	4	int:MTF1
Interaction	HDLBP interactions	FASN ILF3 RBMXL3 FLG2 RBM3 PCSK6 KIF11 DHX9	4.31e-05	855	32	8	int:HDLBP
Interaction	MEPCE interactions	HNRNPA0 ILF3 HRNR RBM3 HNRNPF KIF11 HNRNPU DHX9	4.45e-05	859	32	8	int:MEPCE
Interaction	KRT17 interactions	FASN ILF3 HRNR FLG2 HNRNPU	4.49e-05	252	32	5	int:KRT17
Interaction	DSP interactions	FOXO1 FASN ILF3 HRNR FLG2 HNRNPF	4.71e-05	423	32	6	int:DSP
Interaction	KHDRBS2 interactions	HNRNPA0 ILF3 HRNR RBM3	5.01e-05	129	32	4	int:KHDRBS2
Interaction	CUL1 interactions	SCNN1D HNRNPA0 ILF3 ZNRF3 RBM3 HNRNPF HNRNPU DHX9	5.12e-05	876	32	8	int:CUL1
Interaction	BRD7 interactions	FOXO1 HNRNPA0 FASN ILF3 HNRNPF HNRNPU DHX9	5.15e-05	637	32	7	int:BRD7
Interaction	HNRNPD interactions	FOXO1 HNRNPA0 MCCC2 ILF3 HNRNPF HNRNPU DHX9	5.20e-05	638	32	7	int:HNRNPD
Interaction	EED interactions	HNRNPA0 FASN MCCC2 ILF3 CUBN MYCBP2 HNRNPF KIF11 HNRNPU DHX9	5.21e-05	1445	32	10	int:EED
Interaction	ECT2 interactions	HNRNPA0 FASN ILF3 RBMXL3 MYCBP2 HNRNPF HNRNPU DHX9	5.59e-05	887	32	8	int:ECT2
Interaction	MAGOH interactions	FASN ILF3 RBM3 HNRNPF HNRNPU	5.60e-05	264	32	5	int:MAGOH
Interaction	SNRPC interactions	HNRNPA0 KRTAP7-1 ILF3 HNRNPF HNRNPU DHX9	5.86e-05	440	32	6	int:SNRPC
Interaction	FZR1 interactions	HNRNPA0 FASN ILF3 FLG2 RBM3 HNRNPF KIF11 HNRNPU DHX9	6.12e-05	1172	32	9	int:FZR1
Interaction	AIMP2 interactions	HNRNPA0 FASN ILF3 HRNR HNRNPF HNRNPU	6.32e-05	446	32	6	int:AIMP2
Interaction	CIBAR1 interactions	HRNR HNRNPF KIF11 HNRNPU	6.34e-05	137	32	4	int:CIBAR1
Interaction	NDUFB9 interactions	FASN MCCC2 ILF3 MYCBP2	6.71e-05	139	32	4	int:NDUFB9
Interaction	MALAT1 interactions	HNRNPA0 ILF3 HNRNPF DHX9	6.71e-05	139	32	4	int:MALAT1
Interaction	RC3H2 interactions	HNRNPA0 ILF3 RBM3 HNRNPF KIF11 HNRNPU DHX9	6.89e-05	667	32	7	int:RC3H2
Interaction	CDKN2AIP interactions	AKAP11 ILF3 HNRNPF HNRNPU	6.90e-05	140	32	4	int:CDKN2AIP
Interaction	PCBP1 interactions	HNRNPA0 FASN ILF3 RBM3 HNRNPF HNRNPU DHX9	7.15e-05	671	32	7	int:PCBP1
Interaction	RC3H1 interactions	HNRNPA0 ILF3 RBM3 HNRNPF KIF11 HNRNPU DHX9	7.57e-05	677	32	7	int:RC3H1
Interaction	RNF125 interactions	ILF3 HNRNPU DHX9	8.07e-05	53	32	3	int:RNF125
Interaction	METTL3 interactions	FASN HRNR FLG2 HNRNPF HNRNPU	8.31e-05	287	32	5	int:METTL3
Interaction	VCAM1 interactions	HNRNPA0 FASN ILF3 HNRNPF HNRNPU DHX9	8.94e-05	475	32	6	int:VCAM1
Interaction	TRGV3 interactions	CNTNAP3 CNTNAP3B PCSK6	9.02e-05	55	32	3	int:TRGV3
Interaction	USP4 interactions	HNRNPA0 FASN HNRNPF HNRNPU DHX9	9.16e-05	293	32	5	int:USP4
Interaction	JUP interactions	FOXO1 FASN ILF3 HRNR FLG2 RBM3	1.00e-04	485	32	6	int:JUP
Interaction	HNRNPH3 interactions	FOXO1 HNRNPA0 HNRNPF HNRNPU DHX9	1.04e-04	301	32	5	int:HNRNPH3
Interaction	SNCA interactions	HNRNPA0 FASN ILF3 HNRNPF KIF3A HNRNPU DHX9	1.07e-04	716	32	7	int:SNCA
Interaction	GSPT1 interactions	FOXO1 ILF3 HNRNPF HNRNPU DHX9	1.12e-04	306	32	5	int:GSPT1
Interaction	KIF3B interactions	KIF3A KIF11 HNRNPU	1.17e-04	60	32	3	int:KIF3B
Interaction	SPDL1 interactions	FASN RBM3 KIF11 HNRNPU DHX9	1.29e-04	315	32	5	int:SPDL1
Interaction	MAP4 interactions	FASN ILF3 MYCBP2 HNRNPF KIF11	1.47e-04	324	32	5	int:MAP4
Interaction	CCAT1 interactions	ILF3 HRNR DHX9	1.49e-04	65	32	3	int:CCAT1
Interaction	RCHY1 interactions	HNRNPA0 ILF3 HNRNPF HNRNPU DHX9	1.49e-04	325	32	5	int:RCHY1
Interaction	SRSF3 interactions	HNRNPA0 ILF3 RBM3 HNRNPF HNRNPU DHX9	1.50e-04	522	32	6	int:SRSF3
Interaction	CHD3 interactions	HNRNPA0 ILF3 HRNR FLG2 HNRNPF HNRNPU DHX9	1.52e-04	757	32	7	int:CHD3
Interaction	UFL1 interactions	HNRNPA0 FASN ILF3 FLG2 HNRNPF KIF11 HNRNPU DHX9	1.60e-04	1031	32	8	int:UFL1
Interaction	FAF1 interactions	ILF3 HRNR MYCBP2 HNRNPF HNRNPU	1.69e-04	334	32	5	int:FAF1
Interaction	GPC1 interactions	HNRNPA0 LAMC2 ILF3 HNRNPU	1.78e-04	179	32	4	int:GPC1
Interaction	ITFG1 interactions	HNRNPA0 FASN ILF3 HNRNPF HNRNPU DHX9	1.80e-04	540	32	6	int:ITFG1
Interaction	IVNS1ABP interactions	ILF3 HNRNPF HNRNPU DHX9	1.82e-04	180	32	4	int:IVNS1ABP
Interaction	SMURF1 interactions	HNRNPA0 FASN HNRNPF KIF11 HNRNPU DHX9	1.88e-04	544	32	6	int:SMURF1
Interaction	SNAI1 interactions	FASN ILF3 HNRNPF KIF11 HNRNPU DHX9	1.91e-04	546	32	6	int:SNAI1
Interaction	FIBIN interactions	CNTNAP3 CNTNAP3B PCSK6	1.93e-04	71	32	3	int:FIBIN
Interaction	AGO1 interactions	ILF3 HNRNPF HNRNPU DHX9	1.94e-04	183	32	4	int:AGO1
Interaction	DYRK1A interactions	FOXO1 AKAP11 FASN HRNR MYCBP2 PCSK6	2.03e-04	552	32	6	int:DYRK1A
Interaction	MYCN interactions	HNRNPA0 PLAT ILF3 HRNR FLG2 RBM3 HNRNPF HNRNPU DHX9	2.06e-04	1373	32	9	int:MYCN
Interaction	HNRNPUL1 interactions	HNRNPA0 ILF3 HNRNPF HNRNPU DHX9	2.13e-04	351	32	5	int:HNRNPUL1
Interaction	METTL14 interactions	ILF3 HRNR FLG2 HNRNPF HNRNPU DHX9	2.15e-04	558	32	6	int:METTL14
Interaction	RBX1 interactions	HNRNPA0 MCCC2 ILF3 HNRNPF HNRNPU DHX9	2.15e-04	558	32	6	int:RBX1
Interaction	ANGEL2 interactions	ILF3 HNRNPF HNRNPU	2.18e-04	74	32	3	int:ANGEL2
Interaction	DIMT1 interactions	ILF3 HNRNPF HNRNPU DHX9	2.19e-04	189	32	4	int:DIMT1
Interaction	HSD17B4 interactions	FASN ILF3 HNRNPU DHX9	2.24e-04	190	32	4	int:HSD17B4
Cytoband	21q22.1	KRTAP7-1 KRTAP13-4	3.65e-04	39	33	2	21q22.1
Cytoband	Ensembl 112 genes in cytogenetic band chr21q22	UMODL1-AS1 KRTAP7-1 KRTAP13-4	2.50e-03	377	33	3	chr21q22
Cytoband	5q31	HNRNPA0 KIF3A	3.12e-03	115	33	2	5q31
Cytoband	1q21.3	HRNR FLG2	3.23e-03	117	33	2	1q21.3
Cytoband	Ensembl 112 genes in cytogenetic band chr1q25	LAMC2 DHX9	6.45e-03	167	33	2	chr1q25
Cytoband	14q11.2	CDH24 KLHL33	7.45e-03	180	33	2	14q11.2
GeneFamily	EF-hand domain containing\|S100 fused type protein family	HRNR FLG2	3.24e-05	7	23	2	1350
GeneFamily	RNA binding motif containing	HNRNPA0 RBMXL3 RBM3 HNRNPF	1.39e-04	213	23	4	725
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF3A KIF11	1.55e-03	46	23	2	622
GeneFamily	Keratin associated proteins	KRTAP7-1 KRTAP13-4	8.39e-03	109	23	2	619
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 CNTNAP3B ITGAX PCSK6	1.40e-05	200	33	4	3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FOXO1 CDH24 CUBN PCSK6	1.40e-05	200	33	4	c74bc12e13d002dedaaf75a2244ec111e47524e1
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FOXO1 CDH24 CUBN PCSK6	1.40e-05	200	33	4	ead9eb579bb25fde05fc15602e3d05ab6617f7ac
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 CNTNAP3B ITGAX PCSK6	1.40e-05	200	33	4	97a010a1b6d551239cf6ea5a43319fb413ff180e
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 CNTNAP3B ITGAX PCSK6	1.40e-05	200	33	4	8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672
ToppCell	facs-Marrow-B-cells-24m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNTNAP3 FLG2 ITGAX	1.60e-04	143	33	3	6df16bf0324661cd9707df69cb39f4b5498d6d49
ToppCell	COVID-19-kidney-Lymphatic_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3 CNTNAP3B PCSK6	1.77e-04	148	33	3	f777aa1674e898e2594b2b7c029d3d05dda04df9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLAT CDH24 KIF11	2.07e-04	156	33	3	b3f10cd044f24807576e7d56e51df7064dbf6c50
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MCCC2 CUBN MYCBP2	2.31e-04	162	33	3	d712bc31840ad1523e3dbf884acbb428a8995001
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYCBP2 ITGAX KIF11	2.44e-04	165	33	3	1dcd6b8aa192baeaa1f7bb334843edab6049b96f
ToppCell	normal_Pleural_Fluid-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	LAMC2 PLAT KIF11	2.48e-04	166	33	3	d16af6570806ed2880bd0efb5298932fd2a89cf5
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PLAT	2.52e-04	167	33	3	d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCell	NS-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	UMODL1-AS1 LAMC2 PCSK6	2.66e-04	170	33	3	f6a0162bb690dbc19ff1cec64cb933744ad3b496
ToppCell	Endothelial-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	CNTNAP3 CNTNAP3B PCSK6	2.75e-04	172	33	3	d4e98ff9c7cbc95457e1d71fa60f151a2f178dae
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PCSK6	2.80e-04	173	33	3	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	severe_influenza-Neutrophil\|severe_influenza / disease group, cell group and cell class (v2)	CNTNAP3 CNTNAP3B ITGAX	2.80e-04	173	33	3	615e266419b9f06e964eff73cb466f05451ba0dd
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP11 CDH24 ITGAX	2.85e-04	174	33	3	ccc79febfcf588d8294ffc712338be96de8a5033
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 CNTNAP3B PCSK6	2.90e-04	175	33	3	9d797888edb39fd12fd9cfc698a42b7bed19a5b5
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 CNTNAP3B PCSK6	2.95e-04	176	33	3	682a1dfcc507ec540f5fadf08e872533ea9f0291
ToppCell	facs-Heart-RA-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPA0 MYCBP2 HNRNPU	3.04e-04	178	33	3	b505e2550860e777535ee95f29c936242fd607f1
ToppCell	RV-11._Adipocyte\|RV / Chamber and Cluster_Paper	FOXO1 FASN MYCBP2	3.04e-04	178	33	3	278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3 CNTNAP3B PCSK6	3.09e-04	179	33	3	35fe9961e228ce255e3317fc244efa35b5adbf8b
ToppCell	PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ITGAX PCSK6 KIF11	3.09e-04	179	33	3	df4d0b2fe47d2c7def729b3217cb01ced01495ff
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3 CNTNAP3B PCSK6	3.09e-04	179	33	3	ab3d08b51cd7a37582305615ee221c7a2af83b40
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3B PLAT PCSK6	3.15e-04	180	33	3	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 CNTNAP3B CDH24	3.15e-04	180	33	3	e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 HNRNPU DHX9	3.25e-04	182	33	3	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3 CNTNAP3B PCSK6	3.25e-04	182	33	3	a3c5c0eff527c8d3848acda14af8f9e99c69b0de
ToppCell	Endothelial-A-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CNTNAP3 CNTNAP3B PLAT	3.41e-04	185	33	3	ae49c61f6ecf128fe2a958b8c75c83688da75f59
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3 CNTNAP3B PCSK6	3.41e-04	185	33	3	3be9e05b929ac4d956b1d53284072f668a6c1959
ToppCell	15-Trachea-Epithelial-Multiciliated_precursor\|Trachea / Age, Tissue, Lineage and Cell class	UMODL1-AS1 FAM216A PCSK6	3.41e-04	185	33	3	9a8b8360d99375b726ca8e3c9a3f9b08919892d7
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3 CNTNAP3B PCSK6	3.41e-04	185	33	3	c3dd64a726cb8a1fe048683c266b7532a714a52e
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPA0 RBM3 HNRNPF	3.46e-04	186	33	3	af038994a6c32261f426b0c40c39be4a9099fe43
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3 CNTNAP3B PCSK6	3.46e-04	186	33	3	5d94e6dd2c92e0c46badeb1e6eb54b69af855a66
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CNTNAP3 CNTNAP3B PCSK6	3.46e-04	186	33	3	1da52e13096dfe4eb08bd0e7461cb3809b3b3deb
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PLAT	3.52e-04	187	33	3	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175\|Adult / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PCSK6	3.52e-04	187	33	3	1e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell	RA-11._Adipocyte\|World / Chamber and Cluster_Paper	FOXO1 FASN MYCBP2	3.57e-04	188	33	3	4dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FOXO1 CDH24 CUBN	3.57e-04	188	33	3	ee572246e0c2f41bdbc29a03edc67b831af95c09
ToppCell	Endothelial-endothelial_cell_of_lymph_vessel\|World / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PCSK6	3.57e-04	188	33	3	80910dcbb51990f2baed240f319456c0d3fa2065
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PCSK6	3.57e-04	188	33	3	2db80767903703e7e0a1a37c598f7877a909ee94
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PCSK6	3.57e-04	188	33	3	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PCSK6	3.63e-04	189	33	3	0d18ea72bd58d32a8ab9a61cf97f5786642f804b
ToppCell	facs-Skin-Anagen\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 HNRNPF PCSK6	3.63e-04	189	33	3	adbfc723130079b4caf551f66d2aee86fab1903c
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PCSK6	3.63e-04	189	33	3	55a1776a4ce049959b3f13a43744c7314bc1f00a
ToppCell	COVID-19-lung-Lymphatic_EC\|lung / Disease (COVID-19 only), tissue and cell type	CNTNAP3 CNTNAP3B PCSK6	3.63e-04	189	33	3	c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PCSK6	3.68e-04	190	33	3	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	facs-Skin-Anagen-3m-Epithelial\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 HNRNPF PCSK6	3.68e-04	190	33	3	888ded899f0513d41bf655896d59ae8ef74e0978
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3 CNTNAP3B PCSK6	3.68e-04	190	33	3	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	facs-Skin-Anagen-3m\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 HNRNPF PCSK6	3.68e-04	190	33	3	3466cebab16964e94da130d0673fa32e7d90b5ed
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3B PLAT PCSK6	3.74e-04	191	33	3	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	COVID-19-lung-Lymphatic_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3 CNTNAP3B PCSK6	3.80e-04	192	33	3	cbe57cda44232b183821ac633b60a2668265e616
ToppCell	P07-Endothelial-proliferative_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RBM3 HNRNPF KIF11	3.86e-04	193	33	3	1e95ef29357969ee385b4717c0b5a497390ac260
ToppCell	CF-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	AKAP11 MYCBP2 ITGAX	3.86e-04	193	33	3	7ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCell	P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RBM3 HNRNPF KIF11	3.86e-04	193	33	3	0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 KIF11 DHX9	3.92e-04	194	33	3	8ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FOXO1 CNTNAP3B PLAT	3.92e-04	194	33	3	fc2e0081005c0c496e41197a2d06e4a37708221f
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic-LEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CNTNAP3 CNTNAP3B PCSK6	3.92e-04	194	33	3	f772a9f9ef8635aeaeb8b022dbb94e9672b36ead
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CNTNAP3 CNTNAP3B PCSK6	3.92e-04	194	33	3	5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CNTNAP3 CNTNAP3B PCSK6	3.92e-04	194	33	3	3b73f2d305a7566f7ab567e5f18c82cd3d80e32c
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CNTNAP3 FAM216A PCSK6	3.92e-04	194	33	3	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	droplet-Lung-1m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HNRNPA0 ITGAX HNRNPF	3.92e-04	194	33	3	d16ab5f0cfe73afe6c551fd3123d14784a082f56
ToppCell	droplet-Lung-LUNG-1m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPA0 ITGAX HNRNPF	3.92e-04	194	33	3	621e0e8fe77ff0be83ea9287ce46e97c47e2b3b9
ToppCell	(06)_Krt4/13+-(2)_48hpi\|(06)_Krt4/13+ / shred by cell type and Timepoint	PLAT MCCC2	4.00e-04	40	33	2	1e42cd186ee06ac9345e16ede649a72c15bdf2f8
ToppCell	10x5'v1-week_17-19\|World / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 RBM3 HNRNPF	4.03e-04	196	33	3	31229affb48521e8be93b6061178fd8cea09ba99
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTNAP3 CNTNAP3B PLAT	4.03e-04	196	33	3	5609b2d93172a488b35d854298a3a4e504e17e28
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3 CNTNAP3B LAMC2	4.09e-04	197	33	3	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3 CNTNAP3B CUBN	4.09e-04	197	33	3	ad4a3b5da2190be9495382a2952991e1de9f190d
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	LAMC2 CDH24 KIF11	4.09e-04	197	33	3	1bb8f9535a9ab6c7a444bcbe346fcc0a13b09bdf
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SCNN1D HNRNPA0 HNRNPU	4.09e-04	197	33	3	2b58ac5d70e1ebd9bf9f2b60ee8079337a723658
ToppCell	5'-GW_trimst-1.5-LargeIntestine\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CNTNAP3 HNRNPA0 PLAT	4.09e-04	197	33	3	0b2ad6a933ff1a325649cc8f139380fd158a1d42
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B PLAT CDH24	4.09e-04	197	33	3	b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CNTNAP3 HNRNPA0 PLAT	4.09e-04	197	33	3	5f6fce382f273e789ffbb75b63e9b4e87519918e
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-F\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	PLAT RBM3 PCSK6	4.09e-04	197	33	3	fbff2fb7a8142b88c9dc71aa10980f4350b7e081
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3 CNTNAP3B PCSK6	4.16e-04	198	33	3	b3a020522e064bb61949d38e442f24026e339364
ToppCell	PBMC_fresh-frozen\|World / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYCBP2 RBM3 HNRNPU	4.16e-04	198	33	3	dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3 CNTNAP3B PCSK6	4.16e-04	198	33	3	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HNRNPA0 PLAT HNRNPU	4.16e-04	198	33	3	cd876fba12ff30b74aa507286cb1f3a867011a92
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	CNTNAP3 FOXO1 AKAP11	4.16e-04	198	33	3	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3 CNTNAP3B PLAT	4.22e-04	199	33	3	3a4deea6e11a0555d27497b7c9983350797aac69
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CNTNAP3 HNRNPA0 PLAT	4.22e-04	199	33	3	bb201deb281619113edcd1de2af2d3eb21b967b8
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3 CNTNAP3B PLAT	4.22e-04	199	33	3	bd43a84e84d8acb8e1008b98a235cc5bd5f43586
ToppCell	TCGA-Bile_Duct-Primary_Tumor\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	ILF3 RBM3 HNRNPU	4.28e-04	200	33	3	0350e5ffd36033099b7e32a1fdd790fff99790dc
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 CNTNAP3B PCSK6	4.28e-04	200	33	3	4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c
ToppCell	normal_Lung-Endothelial_cells-Stalk-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	FOXO1 PLAT MYCBP2	4.28e-04	200	33	3	413ac64bbe95b8c921c5396d8b5f298fec8c4f82
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ILF3 MYCBP2 HNRNPU	4.28e-04	200	33	3	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	ILF3 RBM3 HNRNPU	4.28e-04	200	33	3	ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc
ToppCell	mLN-Dendritic_cell-cDC2\|Dendritic_cell / Region, Cell class and subclass	AKAP11 MYCBP2 ITGAX	4.28e-04	200	33	3	e3f7852aaa26a9b3e626d85e40afde799e873045
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 CNTNAP3B PCSK6	4.28e-04	200	33	3	fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3 CNTNAP3B PCSK6	4.28e-04	200	33	3	c6eda342ea0cb37d71d89dbb8d11e819e0745172
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-H\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	HNRNPA0 RBM3 HNRNPF	4.28e-04	200	33	3	0ebc54d19873a2b7b6d12b81559cb12abd73b90c
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FOXO1 CDH24 CUBN	4.28e-04	200	33	3	8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1
Computational	RNA splicing.	HNRNPA0 RBM3 HNRNPF HNRNPU	3.50e-06	65	18	4	MODULE_183
Computational	Neighborhood of DDX5	RBM3 HNRNPU DHX9	1.61e-04	65	18	3	GCM_DDX5
Computational	Cancer module 320: M phase.	ILF3 KIF11	4.94e-04	20	18	2	MODULE_320
Computational	Transcription.	RBM3 HNRNPF HNRNPU	5.11e-04	96	18	3	MODULE_124
Computational	TFs and nuclear.	HNRNPA0 ILF3 HNRNPF DHX9	5.53e-04	237	18	4	MODULE_252
Computational	Genes in the cancer module 198.	HNRNPA0 ILF3 HNRNPF DHX9	1.39e-03	303	18	4	MODULE_198
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3 CNTNAP3B	2.98e-05	8	31	2	DOID:0060308 (implicated_via_orthology)
Disease	autism spectrum disorder (implicated_via_orthology)	CNTNAP3 CNTNAP3B LAMC2	5.42e-04	152	31	3	DOID:0060041 (implicated_via_orthology)
Disease	Acute Cerebrovascular Accidents	ZCCHC14 PLAT	1.48e-03	54	31	2	C0751956
Disease	Cerebrovascular accident	ZCCHC14 PLAT	1.94e-03	62	31	2	C0038454
Disease	diabetes mellitus	MYCBP2 KIF11	2.33e-03	68	31	2	EFO_0000400
Disease	Amphetamine Abuse	PLAT CUBN	2.83e-03	75	31	2	C0236807
Disease	Amphetamine Addiction	PLAT CUBN	2.83e-03	75	31	2	C0236804
Disease	Amphetamine-Related Disorders	PLAT CUBN	2.83e-03	75	31	2	C0236733

Protein segments in the cluster

Peptide	Gene	Start	Entry
GCYSTSSLQGLEYGG	UMODL1-AS1	21	Q8N2C9
GDTYYFGGCLDNSSG	CNTNAP3	486	Q9BZ76
YHSTGSLNGYGCGDN	AKAP11	1521	Q9UKA4
NGRNQGGYDRYSGGN	RBM3	136	P98179
NQTGGLYQCGYSTGA	ITGAX	61	P20702
GQYGSGGSQSCSNGQ	FLG2	381	Q5D862
LYVSGGCGGTGQYLA	KLHL33	371	A6NCF5
IGGSYGAGNYGMCGR	MCCC2	441	Q9HCC0
GYNCTIFAYGQTGTG	KIF11	96	P52732
YGYEGRGSSCGSLSS	CDH24	766	Q86UP0
GNGGREGDYCSCDGY	PCSK6	346	P29122
GRGSYSNRGNYNRGG	HNRNPU	761	Q00839
HGSGSGQDGYSYCKG	HRNR	2801	Q86YZ3
GYNGTIFAYGQTGTG	KIF3A	91	Q9Y496
GCGGYLTGSNNTFAS	CUBN	3156	O60494
GGYSSVSSCNGYGRM	FOXO1	576	Q12778
NSPGGGGGSDYNYES	ILF3	791	Q12906
GGGSSYQGKQGGYSQ	ILF3	841	Q12906
GGLCAYSGGAGYVRS	LYG1	156	Q8N1E2
CNGYSSLGYSFGGSN	KRTAP7-1	46	Q8IUC3
GYGSRCCYSLGNGSS	KRTAP13-4	96	Q3LI77
SGYYNLDGGNPEGCT	LAMC2	171	Q13753
GGGSAGYSCYQNSKG	FAM216A	46	Q8WUB2
SVSCGRGNAGQSNYG	FASN	2021	P49327
STGGDCFYRGYTSGV	SCNN1D	376	P51172
GDTYYFGGCLGNSSG	CNTNAP3B	486	Q96NU0
SGGYGGSANSFRAGY	DHX9	1196	Q08211
GLESQSVSGCYGAGY	HNRNPF	391	P52597
SVSGCYGAGYSGQNS	HNRNPF	396	P52597
YAGGQGYNSIGHFCG	MYCBP2	3266	O75592
GNSDCYFGNGSAYRG	PLAT	211	P00750
SSGQSNCYGGGGRYE	RBMXL3	656	Q8N7X1
QNGLSKGGGGGYNSY	HNRNPA0	206	Q13151
SDYGNGFGGFGSYSQ	HNRNPA0	246	Q13151
CSSGYVSAQQYGGGS	ZCCHC14	831	Q8WYQ9
GGGGSGCYTEDYSVS	ZNRF3	791	Q9ULT6